NASDAQ$JANX

Janux Therapeutics Inc · Q4 2025 earnings

Q4 2025 earnings · · After market close · Investor relations

Reports awaiting report

Janux hasn't published Q4 2025 actuals yet. The tiles below frame what to compare against; sections further down are historical context only.

  • Most recent report

    Q1 2026

    Revenue
    $3.73M
    EPS
    -$0.39
  • Year-ago · Q4 2024

    Q4 2024

    Revenue
    $0.00
    EPS
    -$0.36
  • FY2025 consensus

    Analyst consensus

    Revenue
    $2.79M
    EPS
    -$1.94

Revenue & EPS history

Janux · Revenue · Quarterly

$3.73M

Q1 2026
Beat estimate in 10 of 14 quarters(71%)
ActualEstimate

Historical revenue by segment

Janux · $1.06M total across 1 segment · Q2 2023

  • Collaboration revenue
    $1.06M-55.3%

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q4 2025

Historical avgQ4 2025

+0.6%

Avg return

Earnings day

-1.5%

Avg return

5 days after

-5.5%

Avg return

30 days after

42%

8 / 19 earnings

Positive

+14.6%

Q3 2022

Best reaction

-11.0%

Q1 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-0.6%-1.4%-8.8%
Q4 2025-1.4%+4.0%-4.5%
Q3 2025+3.9%+4.8%-40.1%
Q1 2025-0.8%+3.8%-2.8%
Q4 2024+2.7%-1.6%-9.1%
Q3 2024-1.9%-2.9%+17.6%
Q2 2024-1.1%-0.8%+11.8%
Q1 2024-11.0%-21.3%-31.5%
Q4 2023-1.6%-1.7%-13.5%
Q3 2023+5.9%-3.4%+50.7%
Q2 2023+5.1%+4.3%-11.6%
Q1 2023+1.1%-7.0%-3.5%
Q4 2022-2.5%-4.7%-4.9%
Q3 2022+14.6%+5.3%-9.8%
Q2 2022+1.0%-4.9%-3.2%
Q1 2022+6.1%+13.7%+10.0%
Q4 2021-6.0%-3.5%-17.1%
Q3 2021-1.6%-7.4%-23.9%
Q2 2021-1.0%-3.8%-9.9%
Q1 2021———
Q4 2020———
Q3 2020———
Q2 2020———
Q1 2020———

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro